Skip to content

Clinical trials

Depressive Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Country / region: Canada Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20064
20075
20081
20091
20102
20114
20122
20131
20154
20161
20183
20192
20202
20212
20222
20233
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting7
Terminated4
Unknown status3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Centre for Addiction and Mental Health4
Sanofi3
St. Joseph's Healthcare Hamilton3
Abbott Medical Devices2
Douglas Mental Health University Institute2
Eli Lilly and Company2
Sunnybrook Health Sciences Centre2
University of Alberta2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder49
Major Depressive Disorder22
Mood Disorders13
Depressive Disorder, Treatment-Resistant8
Mental Disorders8
Anxiety Disorders7
Bipolar Disorder5
Stress Disorders, Post-Traumatic4
Psychotic Disorders2
Schizophrenia2

Trials

Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.